Understanding how bacteria resist antimicrobial treatments
Structural Basis of Antimicrobial Peptide Sensing and Resistance
This study is looking at how harmful bacteria manage to survive against treatments that help fight infections, and it’s for anyone interested in understanding how we can develop better ways to tackle drug-resistant infections.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Michigan State University NIH-funded |
| Lab location | 1 site (East Lansing, United States) |
| Project ID | NIH-11097221 on NIH RePORTER |
What this research studies
This research investigates the molecular mechanisms that allow pathogenic bacteria to resist antimicrobial peptides, which are crucial in treating infections. By focusing on specific membrane protein complexes, the research aims to uncover how these bacteria sense and respond to antimicrobial threats. The approach combines advanced techniques like cryo-electron microscopy with biochemical and computational methods to analyze the structure and function of these proteins. This knowledge could lead to new strategies for combating drug-resistant infections.
Who could benefit from this research
Good fit: Ideal candidates for this research are patients suffering from infections caused by drug-resistant bacteria, particularly those involving Gram-positive organisms.
Not a fit: Patients with infections caused by non-bacterial pathogens or those not affected by antimicrobial resistance may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to the development of more effective treatments against drug-resistant bacterial infections.
How similar studies have performed: Other research has shown promise in understanding bacterial resistance mechanisms, making this approach both relevant and potentially impactful.
Where this research is happening
East Lansing, United States
- Michigan State University — East Lansing, United States (Active)
Researchers
- Principal investigator: Orlando, Benjamin Joseph — Michigan State University
- Study coordinator: Orlando, Benjamin Joseph
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.